Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus vs MMF in de Novo Heart Transplant (A2310)
NCT00300274Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2006
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of everolimus in heart transplant rejection, sponsored by Novartis. Started Jan 2006; status: completed.
02
Drugs
everolimus
03
Conditions
heart transplant rejection
Beyond the preview
Go deeper on NCT00300274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300274.